A milestone in_scientific_publishing_print_infographic(1)
•
0 likes•225 views
This infographic summarizes the scientific papers published by the PBPK modeling and simulation group at Certara.
Report
Share
Report
Share
Download to read offline
Recommended
0194MR Impulse Air Article UK VIZ3
This research report evaluated the effects of Milkrite Impulse Air on udder health in dairy cows. The results showed:
1) Teat condition improved for 52.3% of cows and remained the same for 43.5% within two months of using Impulse Air.
2) The tank somatic cell count fell by 12,060 cells per ml in three months, yielding a financial benefit of €7.20 per cow annually.
3) Mastitis cases fell by 4.8% per quarter after switching to Impulse Air, yielding a financial benefit of €44 per cow annually.
Big Data and Precision Dairy Farming
this presentation was prepared for a minisymposium on the occasion of PhD defence of Niels Rutten June 14 2017 at Wageningen University, with the thesis entitled “The utility of sensor technology to support reproductive management on dairy farms”. The public defence of his thesis was a good reason to share knowledge about current sensor research in the dairy farming industry
Emphatize and define jaime betancur
A recent graphic design graduate from Colombia is starting his first job. He feels unprepared for the real world of work after getting poor career advice from his college. While nervous on his first day, working with experienced peers has helped him learn new skills. He worries that with his lack of experience, he may fail or be unable to get good jobs in the future.
IQ consortium survey pkpd modeling in pharma
This infographic summarizes the findings from the IQ consortium survey on the use of preclinical PK/PD modeling in the pharmaceutical industry.
Trevor johnson aaps 2014
Certara's Trevor Johnson gave this presentation, "PBPK in Pediatric Drug Development: Developing the Models, Refining the System Parameters" at the 2014 American Association of Pharmaceutical Scientists meeting.
Reference scaled average bioequivalence analysis
About 20% of generic drugs appear to be highly variable. Because of their highly variability, studies designed to show the bioequivalence of these drugs may require enrolling a large number of subjects. The Reference Scaled Average Bioequivalance (RSABE) approach helps show bioequivalence for highly variable drugs using a typical sample size in order to save money and minimize patient exposure. RSABE can be performed in Phoenix WinNonlni using reusable templates projects and workflows for both the EMA and FDA approaches.
Use of modelling and simulation to assess and manage individualized risk of d...
Assessing an individual's risk of drug-drug interactions is an important step on the way to "personalized medicine." Watch this presentation to learn how modeling and simulation will play a key role in making this vision a reality.
Martinez use of in silico models to support canine drug development
The FDA's Dr. Marilyn Martinez discusses how biosimulation based approaches, such as PBPK modeling, can support developing safer, more effective medications for dogs.
Recommended
0194MR Impulse Air Article UK VIZ3
This research report evaluated the effects of Milkrite Impulse Air on udder health in dairy cows. The results showed:
1) Teat condition improved for 52.3% of cows and remained the same for 43.5% within two months of using Impulse Air.
2) The tank somatic cell count fell by 12,060 cells per ml in three months, yielding a financial benefit of €7.20 per cow annually.
3) Mastitis cases fell by 4.8% per quarter after switching to Impulse Air, yielding a financial benefit of €44 per cow annually.
Big Data and Precision Dairy Farming
this presentation was prepared for a minisymposium on the occasion of PhD defence of Niels Rutten June 14 2017 at Wageningen University, with the thesis entitled “The utility of sensor technology to support reproductive management on dairy farms”. The public defence of his thesis was a good reason to share knowledge about current sensor research in the dairy farming industry
Emphatize and define jaime betancur
A recent graphic design graduate from Colombia is starting his first job. He feels unprepared for the real world of work after getting poor career advice from his college. While nervous on his first day, working with experienced peers has helped him learn new skills. He worries that with his lack of experience, he may fail or be unable to get good jobs in the future.
IQ consortium survey pkpd modeling in pharma
This infographic summarizes the findings from the IQ consortium survey on the use of preclinical PK/PD modeling in the pharmaceutical industry.
Trevor johnson aaps 2014
Certara's Trevor Johnson gave this presentation, "PBPK in Pediatric Drug Development: Developing the Models, Refining the System Parameters" at the 2014 American Association of Pharmaceutical Scientists meeting.
Reference scaled average bioequivalence analysis
About 20% of generic drugs appear to be highly variable. Because of their highly variability, studies designed to show the bioequivalence of these drugs may require enrolling a large number of subjects. The Reference Scaled Average Bioequivalance (RSABE) approach helps show bioequivalence for highly variable drugs using a typical sample size in order to save money and minimize patient exposure. RSABE can be performed in Phoenix WinNonlni using reusable templates projects and workflows for both the EMA and FDA approaches.
Use of modelling and simulation to assess and manage individualized risk of d...
Assessing an individual's risk of drug-drug interactions is an important step on the way to "personalized medicine." Watch this presentation to learn how modeling and simulation will play a key role in making this vision a reality.
Martinez use of in silico models to support canine drug development
The FDA's Dr. Marilyn Martinez discusses how biosimulation based approaches, such as PBPK modeling, can support developing safer, more effective medications for dogs.
Excutive Sum 8 pps
This document summarizes a proposed research project and company called Life Metrics that aims to develop a blood test called BioSpan to predict an individual's remaining lifespan. The research would analyze blood samples and medical records from a large cohort study to identify protein biomarkers correlated with mortality. If successful, BioSpan could be used in financial markets to more accurately assess longevity risk. Life Metrics is seeking $40 million to fund the research and launch commercialization, with projections of over $700 million in annual revenue by year 10 from applications in life insurance, annuities, and other financial planning products.
Interpace Diagnostics Investor Presentation
- IDXG provides molecular diagnostic tests for cancer risk assessment and prognosis.
- Recent accomplishments include new product launches, reimbursement from Aetna for ThyraMir, and achieving approval in New York State.
- The presentation provides financial information, with revenue growing but losses continuing from investments in sales, R&D and administrative expenses.
Big Data in Biomedicine: Where is the NIH Headed
The National Institutes of Health (NIH) is taking actions to address the implications of big data for biomedical research and healthcare. These include developing a "Commons" approach to make data findable, accessible, interoperable and reusable. The NIH is also establishing initiatives like the Precision Medicine Initiative to generate large datasets and the Center for Predictive Computational Phenotyping to develop predictive models from electronic health records. Overall, the NIH aims to train a workforce equipped for data science and facilitate open collaboration to realize the potential of big data for improving health outcomes.
How to model longevity and health effect in 3 months
Healthspan analysis is a huge part of longevity study, which is heavily looked at by many aging labs in recent years. The older we grow, our health will be affected accordingly, and this influence what type of compound we use. To better picture what effects compounds brings to us and to extend lifespan as a goal. A three stage compound assessment is developed by IVB to solve this question.
LLWinter2016 (3)
This document provides an overview of the winter 2016 edition of Biocom's LifeLines publication. It introduces the 10 winners of Biocom's inaugural Life Science Catalyst Awards, who are young entrepreneurs and leaders making significant contributions to the life sciences industry in California. Short profiles of two award winners are provided: Dena Marrinucci, founder of cancer diagnostics startup SalveoDx, and Mike Milligan, who leads the life sciences insurance practice at Barney & Barney. The rest of the document previews various articles in the publication on topics like public policy, partnering conferences, capital development, and Biocom's activities and membership in California.
Uso ed abuso dei farmaci - Applicazione delle informazioni genetiche per un u...
This document summarizes a presentation about pharmacogenetics in neurology and psychiatry. It discusses how genetic information can be used to permit safer and more effective drug use. It provides examples of genetic factors like CYP enzymes and BDNF that influence drug metabolism and efficacy of drugs like SSRIs. It also describes a study that found patients were 42% less likely to not stabilize if they followed recommendations from the Neurofarmagen pharmacogenetic test over 3 months. The presentation promotes combining pharmacogenetics with environmental and drug interaction data to further improve therapeutic outcomes.
WHO Therapeutics and covid 19- living guideline
Therapeutics and COVID-19: Living Guideline - World Health Organization (Launched 06 July 2021)
The evidence base for therapeuqcs for COVID-19 is increasing rapidly, and some treatments of proven benefit have emerged. Numerous randomized trials of many drugs are underway to further inform pracqce. This version of the WHO living guideline contains new informaqon and a recommendaqon on interleukin-6 (IL-6) receptor blockers, including both tocilizumab and
sarilumab (1)(2)(3). Publication of the RECOVERY and REMAP-CAP trials addressing IL-6 receptor blockers as a potenqal treatment for COVID-19 triggered this recommendation.
Know how 30
ERIKS takes an in depth look at hygiene challenges faced by the pharmaceutical and Food & Beverage industries
lab matter
The article discusses how public health laboratories are adapting to new technologies for tuberculosis (TB) testing. At a recent conference, participants debated how to best integrate promising new diagnostic methods like whole genome sequencing while maintaining existing effective testing paradigms. Speakers emphasized the need for laboratories to collaborate and provide accurate, cost-effective information, as well as properly interpret new test results in the context of clinical evidence and conventional test results. Emerging technologies are causing laboratories to reevaluate their testing approaches to make the most of new and existing tools for TB diagnosis and treatment.
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Advisor Live: Advancing Antimicrobial Stewardship
Fight antibiotic resistance! Join us and participate in Get Smart About Antibiotics Week 2016. Medical epidemiologist Dr. Kavita Trivedi will share her deep wealth of knowledge to help your organization implement and meet the challenges of antimicrobial stewardship.
- Current regulatory environment
- Implementation tools available
- Implementation challenges
Pukana partners biotech entrepreneurship
The document discusses four paradoxes of managing high growth biotech ventures:
1) Breakthrough intellectual property often comes from outside the target industry or slow-moving organizations.
2) Entrepreneurship requires individual courage but is also a team sport.
3) Financing covers near-term milestones but companies must plan for the long-term.
4) Plans rarely survive but planning is critical to success.
MentLife, Drug Discovery, Development & Trends, nov 6 2013
The document discusses trends in the pharmaceutical industry from the past to the present and future. It provides background on the speaker, Richard Cook, and his experience working in pharmaceutical research and development. It then covers the history and evolution of the industry, including major companies, mergers and acquisitions, key events, and the development process for new drugs. The challenges facing pharmaceutical research and development are also examined.
17.01.10 coherus jp morgan final
The document provides an overview of Coherus BioSciences and their CHS-1701 pegfilgrastim biosimilar program. Key points include:
[1] CHS-1701 has completed a positive pivotal PK/PD study meeting all primary endpoints and demonstrating similar safety to Neulasta.
[2] Coherus has a strategic manufacturing agreement with KBI to support commercial launch and long-term supply of CHS-1701.
[3] The Neulasta market is very large at over $4B annually in the US and concentrated among a small number of buyers, making it well-suited for a biosimilar.
Team 2
Pluto is a new drug launched by Novartis for resistant and intolerant chronic myeloid leukemia (CML) patients. The goal is to achieve 75% market share within 5 years. Pluto is effective for resistant CML and for patients who cannot tolerate existing treatments. The strategic plan includes increasing awareness of CML, providing psychological support for patients, and making the drug affordable for poor patients through fundraising and discount programs.
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Humanity+2010 june13-d1 s2-ver2-transcripted-noted
morris johnson hplussummit presentation
with the transcript converted to slides..the official unabridged version of HACCP as a lifespan and healthspan comprehensive integrated management system...several other hplus speakers including ronald bailey, maria kovanolenko, aubrey de grey, melanie swan, andrew hessel, robert tercek
Us biosimilars market opportunity & clinical pipeline analysis
“US Biosimilars Market Opportunity & Clinical Pipeline Analysis” Report Highlight:
US Biosimilars Market Introduction
US Biosimilars Regulatory Scenario
Unique Features of US Biosimilars Market
Impact of Biosimilars in US Market
Impact of Reimbursement Policies on US Biosimilars Market
Zarxio: First Approved Biosimilar in US
US Biosimilar Clinical Pipeline By Company, Indication & Phase
US Biosimilar Clinical Pipeline: 104 Biosimilars
Marketed Biosimilars: 1 Biosimilar
Download Us biosimilars market opportunity & clinical pipeline analysis
“US Biosimilars Market Opportunity & Clinical Pipeline Analysis” Report Highlight:
* US Biosimilars Market Introduction
* US Biosimilars Regulatory Scenario
* Unique Features of US Biosimilars Market
* Impact of Biosimilars in US Market
* Impact of Reimbursement Policies on US Biosimilars Market
* Zarxio: First Approved Biosimilar in US
* US Biosimilar Clinical Pipeline By Company, Indication & Phase
* US Biosimilar Clinical Pipeline: 104 Biosimilars
* Marketed Biosimilars: 1 Biosimilar*
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
More Related Content
Similar to A milestone in_scientific_publishing_print_infographic(1)
Excutive Sum 8 pps
This document summarizes a proposed research project and company called Life Metrics that aims to develop a blood test called BioSpan to predict an individual's remaining lifespan. The research would analyze blood samples and medical records from a large cohort study to identify protein biomarkers correlated with mortality. If successful, BioSpan could be used in financial markets to more accurately assess longevity risk. Life Metrics is seeking $40 million to fund the research and launch commercialization, with projections of over $700 million in annual revenue by year 10 from applications in life insurance, annuities, and other financial planning products.
Interpace Diagnostics Investor Presentation
- IDXG provides molecular diagnostic tests for cancer risk assessment and prognosis.
- Recent accomplishments include new product launches, reimbursement from Aetna for ThyraMir, and achieving approval in New York State.
- The presentation provides financial information, with revenue growing but losses continuing from investments in sales, R&D and administrative expenses.
Big Data in Biomedicine: Where is the NIH Headed
The National Institutes of Health (NIH) is taking actions to address the implications of big data for biomedical research and healthcare. These include developing a "Commons" approach to make data findable, accessible, interoperable and reusable. The NIH is also establishing initiatives like the Precision Medicine Initiative to generate large datasets and the Center for Predictive Computational Phenotyping to develop predictive models from electronic health records. Overall, the NIH aims to train a workforce equipped for data science and facilitate open collaboration to realize the potential of big data for improving health outcomes.
How to model longevity and health effect in 3 months
Healthspan analysis is a huge part of longevity study, which is heavily looked at by many aging labs in recent years. The older we grow, our health will be affected accordingly, and this influence what type of compound we use. To better picture what effects compounds brings to us and to extend lifespan as a goal. A three stage compound assessment is developed by IVB to solve this question.
LLWinter2016 (3)
This document provides an overview of the winter 2016 edition of Biocom's LifeLines publication. It introduces the 10 winners of Biocom's inaugural Life Science Catalyst Awards, who are young entrepreneurs and leaders making significant contributions to the life sciences industry in California. Short profiles of two award winners are provided: Dena Marrinucci, founder of cancer diagnostics startup SalveoDx, and Mike Milligan, who leads the life sciences insurance practice at Barney & Barney. The rest of the document previews various articles in the publication on topics like public policy, partnering conferences, capital development, and Biocom's activities and membership in California.
Uso ed abuso dei farmaci - Applicazione delle informazioni genetiche per un u...
This document summarizes a presentation about pharmacogenetics in neurology and psychiatry. It discusses how genetic information can be used to permit safer and more effective drug use. It provides examples of genetic factors like CYP enzymes and BDNF that influence drug metabolism and efficacy of drugs like SSRIs. It also describes a study that found patients were 42% less likely to not stabilize if they followed recommendations from the Neurofarmagen pharmacogenetic test over 3 months. The presentation promotes combining pharmacogenetics with environmental and drug interaction data to further improve therapeutic outcomes.
WHO Therapeutics and covid 19- living guideline
Therapeutics and COVID-19: Living Guideline - World Health Organization (Launched 06 July 2021)
The evidence base for therapeuqcs for COVID-19 is increasing rapidly, and some treatments of proven benefit have emerged. Numerous randomized trials of many drugs are underway to further inform pracqce. This version of the WHO living guideline contains new informaqon and a recommendaqon on interleukin-6 (IL-6) receptor blockers, including both tocilizumab and
sarilumab (1)(2)(3). Publication of the RECOVERY and REMAP-CAP trials addressing IL-6 receptor blockers as a potenqal treatment for COVID-19 triggered this recommendation.
Know how 30
ERIKS takes an in depth look at hygiene challenges faced by the pharmaceutical and Food & Beverage industries
lab matter
The article discusses how public health laboratories are adapting to new technologies for tuberculosis (TB) testing. At a recent conference, participants debated how to best integrate promising new diagnostic methods like whole genome sequencing while maintaining existing effective testing paradigms. Speakers emphasized the need for laboratories to collaborate and provide accurate, cost-effective information, as well as properly interpret new test results in the context of clinical evidence and conventional test results. Emerging technologies are causing laboratories to reevaluate their testing approaches to make the most of new and existing tools for TB diagnosis and treatment.
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Advisor Live: Advancing Antimicrobial Stewardship
Fight antibiotic resistance! Join us and participate in Get Smart About Antibiotics Week 2016. Medical epidemiologist Dr. Kavita Trivedi will share her deep wealth of knowledge to help your organization implement and meet the challenges of antimicrobial stewardship.
- Current regulatory environment
- Implementation tools available
- Implementation challenges
Pukana partners biotech entrepreneurship
The document discusses four paradoxes of managing high growth biotech ventures:
1) Breakthrough intellectual property often comes from outside the target industry or slow-moving organizations.
2) Entrepreneurship requires individual courage but is also a team sport.
3) Financing covers near-term milestones but companies must plan for the long-term.
4) Plans rarely survive but planning is critical to success.
MentLife, Drug Discovery, Development & Trends, nov 6 2013
The document discusses trends in the pharmaceutical industry from the past to the present and future. It provides background on the speaker, Richard Cook, and his experience working in pharmaceutical research and development. It then covers the history and evolution of the industry, including major companies, mergers and acquisitions, key events, and the development process for new drugs. The challenges facing pharmaceutical research and development are also examined.
17.01.10 coherus jp morgan final
The document provides an overview of Coherus BioSciences and their CHS-1701 pegfilgrastim biosimilar program. Key points include:
[1] CHS-1701 has completed a positive pivotal PK/PD study meeting all primary endpoints and demonstrating similar safety to Neulasta.
[2] Coherus has a strategic manufacturing agreement with KBI to support commercial launch and long-term supply of CHS-1701.
[3] The Neulasta market is very large at over $4B annually in the US and concentrated among a small number of buyers, making it well-suited for a biosimilar.
Team 2
Pluto is a new drug launched by Novartis for resistant and intolerant chronic myeloid leukemia (CML) patients. The goal is to achieve 75% market share within 5 years. Pluto is effective for resistant CML and for patients who cannot tolerate existing treatments. The strategic plan includes increasing awareness of CML, providing psychological support for patients, and making the drug affordable for poor patients through fundraising and discount programs.
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Global cancer biosimilars market opportunity outlook
"Global Cancer Biosimilars Market Opportunity Outlook" Report Highlight & Findings:
Introduction & Mechanism of Cancer Biosimilars
Global Cancer Biosimilars Market Dynamics
FDA & EMA Guidelines on Development & Marketing of Biosimilars
Cancer Biosimilars Clinical Pipeline by Company, Indication & Phase
Cancer Biosimilars Clinical Pipeline: 100 Biosimilars
Marketed Cancer Biosimilars Clinical Insight
Marketed Cancer Biosimilars: 15 Biosimilars
Humanity+2010 june13-d1 s2-ver2-transcripted-noted
morris johnson hplussummit presentation
with the transcript converted to slides..the official unabridged version of HACCP as a lifespan and healthspan comprehensive integrated management system...several other hplus speakers including ronald bailey, maria kovanolenko, aubrey de grey, melanie swan, andrew hessel, robert tercek
Us biosimilars market opportunity & clinical pipeline analysis
“US Biosimilars Market Opportunity & Clinical Pipeline Analysis” Report Highlight:
US Biosimilars Market Introduction
US Biosimilars Regulatory Scenario
Unique Features of US Biosimilars Market
Impact of Biosimilars in US Market
Impact of Reimbursement Policies on US Biosimilars Market
Zarxio: First Approved Biosimilar in US
US Biosimilar Clinical Pipeline By Company, Indication & Phase
US Biosimilar Clinical Pipeline: 104 Biosimilars
Marketed Biosimilars: 1 Biosimilar
Download Us biosimilars market opportunity & clinical pipeline analysis
“US Biosimilars Market Opportunity & Clinical Pipeline Analysis” Report Highlight:
* US Biosimilars Market Introduction
* US Biosimilars Regulatory Scenario
* Unique Features of US Biosimilars Market
* Impact of Biosimilars in US Market
* Impact of Reimbursement Policies on US Biosimilars Market
* Zarxio: First Approved Biosimilar in US
* US Biosimilar Clinical Pipeline By Company, Indication & Phase
* US Biosimilar Clinical Pipeline: 104 Biosimilars
* Marketed Biosimilars: 1 Biosimilar*
Similar to A milestone in_scientific_publishing_print_infographic(1) (20)
How to model longevity and health effect in 3 months
How to model longevity and health effect in 3 months
Uso ed abuso dei farmaci - Applicazione delle informazioni genetiche per un u...
Uso ed abuso dei farmaci - Applicazione delle informazioni genetiche per un u...
Global cancer biosimilars market opportunity outlook
Global cancer biosimilars market opportunity outlook
MentLife, Drug Discovery, Development & Trends, nov 6 2013
MentLife, Drug Discovery, Development & Trends, nov 6 2013
Global cancer biosimilars market opportunity outlook
Global cancer biosimilars market opportunity outlook
Global cancer biosimilars market opportunity outlook
Global cancer biosimilars market opportunity outlook
Humanity+2010 june13-d1 s2-ver2-transcripted-noted
Humanity+2010 june13-d1 s2-ver2-transcripted-noted
Us biosimilars market opportunity & clinical pipeline analysis
Us biosimilars market opportunity & clinical pipeline analysis
Download Us biosimilars market opportunity & clinical pipeline analysis
Download Us biosimilars market opportunity & clinical pipeline analysis
Recently uploaded
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
DECLARATION OF HELSINKI - History and principles
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Cervical Disc Arthroplasty ORSI 2024.pptx
Indication and installation of a mobile cervical disc prosthesis. Benefits of the PRODISC C VIVO mobile disc prosthesis (Centinel Spine)
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
This quiz was conducted as a promotional event for the 2024 Annual Meet of Kerala Chapter of API.
More than 20 participants took part everyday !
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
vonoprazan A novel drug for GERD presentation
Vonoprazan, a new potassium acid channel blocker used in the conditions of GERD and gastric ulcer, duodenal ulcer ....
How to choose the best dermatologists in Indore.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Recently uploaded (20)
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
A milestone in_scientific_publishing_print_infographic(1)
- 1. The top 3 citation areas were: Drug-Drug Interactions (DDI): 33% PBPK Strategy/Regulatory: 11% Pediatrics: 11% Simcyp Consortium members have leveraged our products, the Simcyp Simulator, Simcyp Pediatric, and the Cardiac Safety Simulator, to support more than 50 publications in the last 2 years. For more information, visit www.certara.com © Copyright Certara 2015 IGO615-US-03 Our scientists have published papers using the Simcyp Simulator to study pharmacokinetics in virtual populations including: Pregnant Women Bariatric/Obese Patients Patients with Renal Impairment The top 3 areas we published in were: Pediatrics: 33% Biologics: 17% Cardiac Safety: 17% A Milestone in Scientific Publishing We hit a landmark in scientific contributions for Physiologically Based Pharmacokinetic (PBPK) modeling and simulation: 100+ papers published over the past eight years!